Deepali Verma
Overview
Explore the profile of Deepali Verma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Batura N, Roy R, Aziz S, Sharma K, Kumar D, Verma D, et al.
Front Pediatr
. 2023 Jul;
11:1120253.
PMID: 37484767
Introduction: Intervention strategies that seek to improve early childhood development outcomes are often targeted at the primary caregivers of children, usually mothers. The interventions require mothers to assimilate new information...
2.
Kirkwood B, Sikander S, Roy R, Soremekun S, Bhopal S, Avan B, et al.
Front Nutr
. 2023 Jul;
10:1155763.
PMID: 37404861
Introduction: Almost 250 million children fail to achieve their full growth or developmental potential, trapping them in a cycle of continuing disadvantage. Strong evidence exists that parent-focussed face to face...
3.
Hill Z, Zafar S, Soremekun S, Sikander S, Avan B, Roy R, et al.
Front Nutr
. 2023 Jul;
10:1152548.
PMID: 37404854
Introduction: There is limited evidence from low and middle-income settings on the effectiveness of early child development interventions at scale. To bridge this knowledge-gap we implemented the SPRING home visiting...
4.
Bhopal S, Roy R, Verma D, Kumar D, Khan B, Soremekun S, et al.
Wellcome Open Res
. 2022 Mar;
6:54.
PMID: 35224208
The World Health Organization and others promote responsive caregiving to support all children to thrive, particularly in low- and middle-income countries. The 14-item Mother's Object Relations Scales - Short Form...
5.
Verma D, Gupta V
3 Biotech
. 2021 Aug;
11(8):373.
PMID: 34367865
The antimicrobial resistant strains of several pathogens are major culprits of hospital-acquired nosocomial infections. An active and urgent action is necessary against these pathogens for the development of unique therapeutics....
6.
Boucheron P, Bhopal S, Verma D, Roy R, Kumar D, Divan G, et al.
PLoS One
. 2020 Aug;
15(8):e0237226.
PMID: 32790783
Background: Child undernutrition results in poor growth in early childhood, undermines optimal development and increases the risk of mortality. Responsive feeding has been promoted as a key intervention for improving...
7.
Mukherjee D, Bhavnani S, Swaminathan A, Verma D, Parameshwaran D, Divan G, et al.
Front Psychol
. 2020 Jun;
11:1202.
PMID: 32587551
Over 250 million children in developing countries are at risk of not achieving their developmental potential, and unlikely to receive timely interventions because existing developmental assessments that help identify children...
8.
Verma D, Gupta S, Saxena R, Kaur P, R R, Srivastava S, et al.
Int J Biol Macromol
. 2019 Nov;
151:1240-1249.
PMID: 31751684
The emergence and spread of multidrug-resistant strains of Klebsiella pneumoniae is a major concern that necessitates the development of unique therapeutics. The essential requirement of serine acetyltransferase (SAT/CysE) for survival...
9.
Bhopal S, Verma D, Roy R, Divan G, Hill Z, Kirkwood B
Wellcome Open Res
. 2019 Jul;
3:153.
PMID: 31304286
Exposure to a range of biological and psychosocial adversities in early childhood is of negative consequence through the lifecourse. This is particularly important for children in low- and middle-income countries...
10.
Bhopal S, Verma D, Roy R, Soremekun S, Kumar D, Bristow M, et al.
Psychoneuroendocrinology
. 2019 Jun;
107:241-250.
PMID: 31174162
Background: The majority of the world's children live in low- and middle-income countries and face multiple obstacles to optimal wellbeing. The mechanisms by which adversities - social, cultural, psychological, environmental,...